학술논문

Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients.
Document Type
article
Source
Neurology. 92(12)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Clinical Research
Diabetes
HIV/AIDS
Aetiology
2.1 Biological and endogenous factors
Adult
Anti-HIV Agents
C-Peptide
Case-Control Studies
Cognition
Cognitive Dysfunction
Cohort Studies
Female
HIV Infections
Humans
Hyperinsulinism
Insulin Resistance
Lipoproteins
Male
Middle Aged
Clinical Sciences
Neurosciences
Cognitive Sciences
Neurology & Neurosurgery
Clinical sciences
Language
Abstract
ObjectiveTo determine the association of insulin sensitivity and metabolic status with declining cognition in HIV-infected individuals.MethodsWe conducted targeted clinical and metabolic measures in longitudinal plasma samples obtained from HIV-infected patients enrolled in the Central Nervous System HIV Anti-Retroviral Therapy Effects Research Study (CHARTER). Findings were validated with plasma samples from the Multicenter AIDS Cohort Study (MACS). Patients were grouped according to longitudinally and serially assessed cognitive performance as having stably normal or declining cognition.ResultsPatients with declining cognition exhibited baseline hyperinsulinemia and elevated plasma c-peptide levels with normal c-peptide/insulin ratios, suggesting that insulin production was increased, but insulin clearance was normal. The association of hyperinsulinemia with worsening cognition was further supported by low high-density lipoprotein (HDL), high low-density lipoprotein/HDL ratio, and elevated cholesterol/HDL ratio compared to patients with stably normal cognition.ConclusionsThese findings suggest that hyperinsulinemia and impaired insulin sensitivity are associated with cognitive decline in antiretroviral therapy-treated HIV-infected patients.